Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

In vitro evaluation of ertapenem (MK-0826), a long-acting carbapenem, tested against selected resistant strains.

Journal of chemotherapy (Florence, Italy) - 1 Aug 2001

Jones R N

Abstract excerpt

Ertapenem (MK-0826) is a novel, long-acting parenteral carbapenem. The purpose of this in vitro study was to test ertapenem's activity against a collection of multiply-resistant strains of gram-positive and -negative bacteria isolated from locations worldwide, and to examine its bactericidal activity and ability to act in a synergistic manner in combination with other antimicrobial agents. Ertapenem was active...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Infective Agents
Share to Carbapenems
Share to Ciprofloxacin

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Synergism

Share to Gentamicins

Share to Gram-Negative Aerobic Bacteria

Share to Gram-Positive Bacteria

Share to Molecular Structure

Source

Identifiers

PMID: 11589478
DOI: 10.1179/joc.2001.13.4.363

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 10 closest

In vitro evaluation of ertapenem (MK-0826), a long-acting carbapenem, tested against selected resistant strains.PMID 11589478Read ↗

Activity of ertapenem (MK-0826) versus Enterobacteriaceae with potent beta-lactamases.Semantic proximity Read ↗

Phenotypic changes in a laboratory-derived ertapenem-resistant Escherichia coli strain.Semantic proximity Read ↗

Frequent emergence of porin-deficient subpopulations with reduced carbapenem susceptibility in ESBL-producing Escherichia coli during exposure to ertapenem in an in vitro pharmacokinetic model.Semantic proximity Read ↗

Ertapenem resistance among extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae isolates.Semantic proximity Read ↗

Pharmacodynamic activity of ertapenem versus multidrug-resistant genotypically characterized extended-spectrum beta-lactamase-producing Escherichia coli using an in vitro model.Semantic proximity Read ↗

Prevalence and characteristics of ertapenem-resistant Klebsiella pneumoniae isolates in a Taiwanese university hospital.Semantic proximity Read ↗

[In vitro emergence of ertapenem resistance in Escherichia coli producing extended-spectrum β-lactamase].Semantic proximity Read ↗

Antimicrobial activity of DU-6681a, a parent compound of novel oral carbapenem DZ-2640.Semantic proximity Read ↗

Activities of doripenem (S-4661) against drug-resistant clinical pathogens.Semantic proximity Read ↗

Activity of cefditoren against respiratory pathogens.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.